HIV-1 p17 Gag 77-86 (HLA-A*02:01)
- Order number: EP11254_1
SLYNTVATLY is a linear peptidic epitope (epitope ID 190980) studied as part of Gag polyprotein from Human immunodeficiency virus 1 and Gag-Pol polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide HIV-1 p17 Gag 77-86 (HLA-A*02:01) SLYNTVATLY for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.SLYNTVATLY is a linear peptidic epitope (epitope ID 190980) studied as part of Gag polyprotein from Human immunodeficiency virus 1 and Gag-Pol polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide HIV-1 p17 Gag 77-86 (HLA-A*02:01) SLYNTVATLY for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
| Sequence: | SLYNTVATLY | |
| Gene: | gag-pol | |
| Delivery: | 3 weeks | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Purity: | 95% | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Gag-Pol polyprotein | |
| Species: | HIV-1 | |
| Allele: | HLA-A*02:01 | |
| Application : | Flow Cytometry Immunohistochemistry | |
| Indication : | AIDS (HIV) |
Protocols and Tips
Data sheets